In addition to the annual report, all shareholders will, for the first time, receive a copy of AstraZeneca's 2002 Summary Corporate Responsibility Report, which provides the main points of the company's approach to corporate responsibility as well as 2002 performance highlights. Detailed statistics and further information about our policies and commitment to corporate responsibility are available in our CR section.

AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $17.8 billion and leading positions in sales of gastrointestinal, oncology, anaesthesia (including pain management), cardiovascular, central nervous system (CNS) and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index.